Hypertension during pregnancy

Published on 10/03/2015 by admin

Filed under Obstetrics & Gynecology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1478 times

Chapter 19 HYPERTENSION DURING PREGNANCY

Hypertension is defined as systolic blood pressure of 140 or higher, a diastolic blood pressure of 90 or higher, or both. Women with hypertension during pregnancy need to be monitored carefully because of the significant risk of morbidity and mortality in the mother, fetus, and newborn. Hypertension during pregnancy is classified as gestational hypertension, preeclampsia, eclampsia, or chronic hypertension.

Gestational hypertension is hypertension that develops after 20 weeks of pregnancy and resolves by 12 weeks post partum. About 25% of women with gestational hypertension develop preeclampsia. Preeclampsia is gestational hypertension that is associated with proteinuria (≥0.3 g of protein/24 hours). Eclampsia is the presence of seizures in a pregnant woman with preeclampsia.

Risk factors for preeclampsia include first pregnancy, multiple fetuses, chronic hypertension, diabetes, renal disease, thrombophilia, vascular and connective tissue disease, obesity, maternal age of greater than 35 years, or maternal age of less than 20 years.

Chronic hypertension is hypertension that starts before the 20th week of pregnancy. Patients with chronic hypertension are at considerable risk of developing superimposed preeclampsia. Possible complications of chronic hypertension include preterm labor, intrauterine growth restriction, fetal death, and placental abruption.

Suggested Work-Up

Urinalysis To evaluate for proteinuria and glucosuria
Twenty-four-hour urine sampling for total protein or spot urine protein/creatinine ratio To evaluate for and quantify proteinuria
Complete blood cell count Because hemoconcentration occurs with preeclampsia and because hemolysis and thrombocytopenia may be associated with preeclampsia as part of the syndrome of hemolysis, elevated liver enzyme counts, and low platelet count (HELLP)
Serum creatinine measurement Elevated creatinine levels may be associated with chronic kidney disease or preeclampsia

In women who develop hypertension after 20 weeks, the following testing should be performed in addition to the tests just described:

Uric acid measurement Elevated uric acid level is associated with preeclampsia
Lactate dehydrogenase (LDH) measurement Elevated LDH level may be a sign of hemolysis
Partial thromboplastin time (PTT), prothrombin time (PT), and international normalized ratio (INR) measurements To evaluate for coagulopathy
Alanine transaminase (ALT) and aspartate transaminase (AST) measurements Elevated liver enzyme levels are suggestive of severe preeclampsia

Additional Work-Up

Obstetric ultrasonography Baseline ultrasonography should be performed at 18 to 20 weeks of pregnancy
  According to the Working Group on High Blood Pressure in Pregnancy, ultrasonography for fetal growth and amniotic fluid should be repeated every 3 weeks in patients with mild preeclampsia if the sonograms are normal
  In patients with chronic hypertension, ultrasonography should be repeated only if there is a change in maternal or fetal condition or if fetal growth cannot be assessed through fundal height measurement (e.g., with maternal obesity)
Nonstress test and biophysical profile Both should be performed regularly to evaluate fetal well-being
Electrocardiography To evaluate for evidence of left ventricular hypertrophy in patients with chronic hypertension
Echocardiography May be considered in patients with chronic hypertension to evaluate for left ventricular hypertrophy